“Theater for a New Audience . . . remains the most sophisticated purveyor of revivals in the major Off-Broadway leagues.”
– Charles Isherwood, The New York Times
For more than three decades, the Theatre has produced over 60 master works, including 28 of Shakespeare’s plays alongside other classic works and distinguished contemporary plays, including Edward Bond’s Chair, W.S. Gilbert’s Engaged, Howard Brenton’s Sore Throats, and Adrienne Kennedy’s Ohio State Murders, which was named one of the ten best productions of 2007 by The New York Times. In 2001, Theatre for a New Audience became the first American theatre company invited to perform Shakespeare at the Royal Shakespeare Company (RSC) in Stratford-upon-Avon. Its production of Cymbeline, directed by Bartlett Sher, led to continuing artistic dialogue and exchange, and the Theatre returned to the RSC in March 2007 with its production of The Merchant of Venice, directed by Darko Tresnjak and starring Academy Award-winner F. Murray Abraham.
The Theatre’s productions consistently have earned prestigious nominations and awards, including the Drama Desk, OBIE, Drama League, Outer Critics Circle, Lucille Lortel and Tony.
Theatre for a New Audience is dedicated to the language and ideas of writers: to a dialogue between Shakespeare and a provocative range of classical and contemporary playwrights, such as Christopher Marlowe, Edward Bond and Adrienne Kennedy. The Theatre has attracted some of the world’s most talented and sought-after artists, including directors Sir Peter Hall (Founder, Royal Shakespeare Company), Peter Brook, Doug Hughes (Tony Award, Doubt), Bartlett Sher (Tony Award, South Pacific), Julie Taymor (Tony Award, The Lion King), Darko Tresnjak (former Artistic Director, The Old Globe, San Diego), Kate Whoriskey (Artistic Director, Intiman Theatre), Robert Woodruff (former Artistic Director, American Repertory Theatre), and Evan Yionoulis; as well as distinguished actors, such as F. Murray Abraham, Kathleen Chalfant (Wit), Stephen Spinella (Angels in America), and Mark Rylance (Tony Award, Boeing–Boeing, Jerusalem). At the same time, the Theatre has provided important developmental opportunities for some of today’s most promising artists.
The Theatre also has developed strong partnerships with outstanding presenters and regional theatres in the US and abroad, extending the reach of its work as well as its resources. The Theatre has toured its productions to La Jolla Playhouse and to Intiman Theatre in Seattle. It has mounted co-productions with New York Theatre Workshop, American Repertory Theatre, Berkeley Repertory Theatre, Houston’s Alley Theatre, and Shakespeare’s Globe in London. In addition to its tours to the Royal Shakespeare Company, in January 2006, Theatre for a New Audience had its debut in Italy when it toured to Naples with its production of Eduardo De Filippo’s Souls of Naples (Questi Fantasmi!) starring John Turturro and directed by Roman Paska.
In addition, Theatre for a New Audience sustains the largest program in New York City’s Public Schools for introducing Shakespeare. The Theatre provides teachers with professional development, places artists in-residence in the classroom and brings students to matinee performances of the same award-winning productions seen by the Theatre’s adult audiences. More than two thousand students take part each year and roughly 123,000 have been served since the program began in 1984. Additional artistic programming includes Theatre for a New Audience Talks, a distinctive post-performance discussion series for general audiences. The Theatre also offers a wide range of ticket prices to minimize economic barriers for all its audiences. These endeavors are grounded in the belief that the language and scope of classic drama belong to everyone.
Theatre for a New Audience is also at a turning point in its history: In April 2011, it broke ground on its first home after over thirty years of itinerancy, a 299-seat theatre in Downtown Brooklyn’s BAM Cultural District. Of a three phase Capital Campaign goal of $68.5 million, the Theatre has raised $53.4 million—and is on track and on budget to provide New York and the region with a state of the art theatre dedicated to Shakespeare.